Why intellectual property rights matter for COVID-19
The IP system has been crucial in underpinning the research, development and manufacture of vaccines and therapeutics for COVID-19, proving critics of IP wrong at every step of this crisis.
The IP system has been crucial in underpinning the research, development and manufacture of vaccines and therapeutics for COVID-19, proving critics of IP wrong at every step of this crisis.
Creative industries hold the key for Asian countries looking to unlock new sources of economic growth as the Covid pandemic recedes. Movies, television and other video content employ hundreds of thousands and contribute billions – USD108.4bn per year in China alone.
As the 2020 World Health Assembly re-convenes in Geneva, an international coalition of think tanks urges governments to commit to simple reforms to accelerate access to medicines, including those in the process of being developed for Covid-19.
As the UK develops its trade policy outside of the EU, it would be a mistake to base its future approach on the one it inherits from the EU.
With its human resources, connected location and economic reform ambitions, Saudi Arabia could yet emerge from the Covid crisis as a global competitor in knowledge-based industries.
Experts from the life science and research community explain the crucial role of intellectual property rights in developing new vaccines and therapeutics for Covid-19.
La siguiente es una declaración de principios sobre la compra de medicamentos emitida en conjunto por centros de estudios de Argentina, Brasil, Chile, Colombia y México.
The WHO has a crucial role in coordinating the global response to pandemics and health emergencies, but this important work is undermined by strategic incoherence and an ideological approach to policymaking.
90% of medicines on the World Health Organization’s Model List of Essential Medicines are off-patent, while many low-income countries have no essential medicine patents at all, according to this Geneva Network research paper.